Northlink Fiscal (539110)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹67.42 |
| Market Cap | ₹23.02 Cr |
| P/E Ratio | 0 |
| ROCE | -10.1% |
| ROE | -9.21% |
| Dividend Yield | 0% |
| Profit Growth | -466.67% |
| Debt/Equity | — |
| Sales Growth | -69.23% |
| 52-Week Range | ₹14.31 — ₹67.42 |
| Sector | Finance |
| Book Value | ₹10.96 |
Strengths
- Positive book value of ₹10.96 per share provides a minimum net asset base.
- Small market cap of ₹23 Cr means a small absolute profit recovery could materially affect per-share metrics.
- Stock is at the top of its 52-week range, showing clear market interest.
- No dividend payout means cash is not being drained via distributions.
- Latest quarterly net loss is modest at ₹1 Cr, so near-term cash burn is not catastrophic.
Concerns
- Zero latest-quarter sales and -69.23% sales growth show severely impaired business activity.
- Negative ROE of -9.21%, ROCE of -10.10%, and profit growth of -466.67% point to continuing value destruction.
- P/B of 6.15 versus book value of ₹10.96 means the price is far above any fundamental asset anchor.
- Piotroski F-Score of 2/9, with no promoter holding or debt/equity disclosure, makes analytical confidence very low.
AI Analysis
Let me start with the obvious: a P/E of 0.00 is not a number I celebrate; it is the market's way of saying there are no earnings to place a multiple on. Northlink Fiscal's latest quarter shows zero sales and a net loss of ₹1 Cr. Annual profit growth is -466.67%, and sales growth is -69.23%. This is a business in retreat, not one building a moat. The Piotroski score of 2/9 confirms poor financial health. As Graham would say, price is what you pay, value is what you get. Here, I am asked to pay ₹67.42 for a share whose book value is only ₹10.96 — more than six times book for a company earning a negative ROE of -9.21% and ROCE of -10.10%. That is not value; that is hope. A 52-week range from ₹14.31 to ₹67.42 tells me the stock has caught speculative fire, but speculation does not compound. There is no dividend, no positive earnings, and no sales in the latest quarter to anchor valuation. Perhaps the company is attempting a turnaround, but I see no evidence of it in these figures. The market cap is tiny at ₹23 Cr, so a small revival could move the numbers, but that is in the realm of venture speculation, not investment. I cannot call this a cigar butt: it has positive book value, but I must pay a huge premium for it. Until I see sales, profits, and a credible management plan, this is a pass. In investing, you do not need to swing at every pitch; this one, I let go.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer